TheProfitWatch

MBIO - Mustang Bio, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.14 0.05 (4.54%) --- --- 0.03 (2.74%) 0.01 (0.88%) 0.01 (1.0%) -0.04 (-3.48%) 0.0 (0.0%)

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-6.2726
Diluted P/E:
-6.2726
RSI(14) 1m:
76.95
VWAP:
1.19
RVol:

Events

Period Kind Movement Occurred At

Related News